Characteristics | CENP-F (%) | P | |
---|---|---|---|
 | Low expression | High expression |  |
Gender | Â | Â | Â |
   Male | 73 (48.3) | 78 (51.7) |  |
   Female | 31 (60.7) | 20 (39.3) | 0.124 |
Age (y) | Â | Â | Â |
   ≤ 45 | 49 (54.4) | 41(45.6) |  |
   > 45 | 55 (49.1) | 57 (50.9) | 0.451 |
Histologic classification | Â | Â | Â |
   Type II | 4 (40.0) | 6 (60.0) |  |
   Type III | 100 (52.1) | 92 (47.9) | 0.528* |
Clinical stage (92 stage) | Â | Â | Â |
   I-II | 65 (75.6) | 21 (24.4) |  |
   III-IV | 39(33.6) | 77 (66.4) | < 0.001 |
T classification | Â | Â | Â |
   T1-T2 | 82 (66.1) | 42 (33.9) |  |
   T3-T4 | 22 (28.2) | 56 (71.8) | < 0.001 |
N classification | Â | Â | Â |
   N0 | 65 (55.1) | 53 (44.9) |  |
   N1-3 | 39 (46.4) | 45 (53.6) | 0.225 |
Distant metastases | Â | Â | Â |
   No | 97 (54.8) | 80(45.2) |  |
   Yes | 7 (28.0) | 18 (72.0) | 0.012 |
Skull-base invasion | Â | Â | Â |
   No | 92 (57.9) | 67 (42.1) |  |
   Yes | 12(27.9) | 31 (72.1) | < 0.001 |